The goal of the proposed study is to investigate the role of two embryonic signaling pathways, Hedgehog and Wnt, during the formation and growth of pancreatic adenocarcinoma. Pancreatic adenocarcinoma constitutes a devastating disease that is marked by a poor prognosis due to late detection, aggressive nature, and early metastasis of transformed cells. The proposed studies are designed to test whether ectopic activation of Hedgehog and Wnt signaling can activate tumor formation and if inhibition of these pathways induces tumor regression. We hypothesize that deregulation of either pathway is sufficient to induce tumorigenesis in pancreatic tissue and that their continued activities are required for tumor survival. Our general approach is to use a combination of cell culture assays and transgenic mouse experiments to deregulate the activity levels of both pathways in normal and transformed pancreatic cells. The first specific aim is to determine if uncontrolled Hedgehog signaling is one of the earliest events during formation of pancreatic adenocarcinoma. We propose to establish cell culture and in vivo model systems to study the formation of pancreatic cancer. The second specific aim is to determine if inhibition of Wnt signaling is sufficient to block proliferation and cause apoptosis in pancreatic adenocarcinoma cells. We will also test if ectopic activation of Wnt signaling in cultured pancreatic duct cells, as well as in mature pancreatic tissue in vivo, induces adenocarcinoma formation. The third specific aim is to determine if the Hedgehog and Wnt signaling pathways regulate each other's activities and whether growth and survival of pancreatic cancer cells depends on their cooperative functions. In summary, we will explore if deregulation of embryonic signaling pathways is implicated in the development and survival of pancreatic adenocarcinoma. We anticipate that these studies will improve our understanding of the molecular causes of this cancer. In the best case, they will help to design new strategies for treatment of human patients suffering from this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA112537-05
Application #
7458929
Study Section
Clinical and Integrative Gastrointestinal Pathobiology Study Section (CIGP)
Program Officer
Mietz, Judy
Project Start
2004-09-01
Project End
2009-11-30
Budget Start
2008-07-01
Budget End
2009-11-30
Support Year
5
Fiscal Year
2008
Total Cost
$265,033
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ivry, Sam L; Sharib, Jeremy M; Dominguez, Dana A et al. (2017) Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clin Cancer Res 23:4865-4874
Roy, Nilotpal; Takeuchi, Kenneth K; Ruggeri, Jeanine M et al. (2016) PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes Dev 30:2669-2683
Roy, Nilotpal; Malik, Shivani; Villanueva, Karina E et al. (2015) Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev 29:658-71
von Figura, Guido; Fukuda, Akihisa; Roy, Nilotpal et al. (2014) The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 16:255-67
von Figura, Guido; Morris 4th, John P; Wright, Christopher V E et al. (2014) Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut 63:656-64
Greer, Renee L; Staley, Binnaz K; Liou, Angela et al. (2013) Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia. Gastroenterology 145:1088-1097.e8
Stanger, Ben Z; Hebrok, Matthias (2013) Control of cell identity in pancreas development and regeneration. Gastroenterology 144:1170-9
Zhang, Yaqing; Morris 4th, John P; Yan, Wei et al. (2013) Canonical wnt signaling is required for pancreatic carcinogenesis. Cancer Res 73:4909-22
Lin, Wan-chi; Rajbhandari, Nirakar; Liu, Chengbao et al. (2013) Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Res 73:1821-30
Fukuda, Akihisa; Morris 4th, John P; Hebrok, Matthias (2012) Bmi1 is required for regeneration of the exocrine pancreas in mice. Gastroenterology 143:821-831.e2

Showing the most recent 10 out of 32 publications